4.4 Article

The value of novelty in schizophrenia

Journal

SCHIZOPHRENIA RESEARCH
Volume 192, Issue -, Pages 287-293

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.schres.2017.05.007

Keywords

Schizophrenia; Aberrant salience; Decision-making; Novelty; Psychosis; Novelty-seeking

Categories

Funding

  1. National Institute for Health Research Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust
  2. European Research Council Consolidator Award
  3. Institute of Psychiatry, Psychology & Neuroscience King's College

Ask authors/readers for more resources

Influential models of schizophrenia suggest that patients experience incoming stimuli as excessively novel and motivating, with important consequences for hallucinatory experience and delusional belief. However, whether schizophrenia patients exhibit excessive novelty value and whether this interferes with adaptive behaviour has not yet been formally tested. Here, we employed a three-armed bandit task to investigate this hypothesis. Schizophrenia patients and healthy controls were first familiarised with a group of images and then asked to repeatedly choose between familiar and unfamiliar images associated with different monetary reward probabilities. By fitting a reinforcement-learning model we were able to estimate the values attributed to familiar and unfamiliar images when first presented in the context of the decision-making task. In line with our hypothesis, we found increased preference for newly introduced images (irrespective of whether these were familiar or unfamiliar) in patients compared to healthy controls and this to correlate with severity of hallucinatory experience. In addition , we found a correlation between value assigned to novel images and task performance, suggesting that excessive novelty value may interfere with optimal learning in patients, putatively through the disruption of the mechanisms regulating exploration versus exploitation. Our results suggest excessive novelty value in patients, whereby even previously seen stimuli acquire higher value as the result of their exposure in a novel context-a form of 'hyper novelty' which may explain why patients are often attracted by familiar stimuli experienced as new. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Visual Population Receptive Fields in People with Schizophrenia Have Reduced Inhibitory Surrounds

Elaine J. Anderson, Marc S. Tibber, D. Sam Schwarzkopf, Sukhwinder S. Shergill, Emilio Fernandez-Egea, Geraint Rees, Steven C. Dakin

JOURNAL OF NEUROSCIENCE (2017)

Article Psychiatry

Aberrant Force Processing in Schizophrenia

Cristina Martinelli, Francesco Rigoli, Sukhwinder S. Shergill

SCHIZOPHRENIA BULLETIN (2017)

Article Pharmacology & Pharmacy

Patient attitudes to clozapine initiation

Siobhan H. Gee, Sukhwinder S. Shergill, David M. Taylor

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2017)

Article Pharmacology & Pharmacy

Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis

George Joy, Eromona Whiskey, Mark Bolstridge, Alejandro Porras-Segovia, Theresa A. McDonagh, Carla M. Plymen, Sukhi S. Shergill

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)

Article Medicine, Research & Experimental

Realising stratified psychiatry using multidimensional signatures and trajectories

Dan W. Joyce, Angie A. Kehagia, Derek K. Tracy, Jessica Proctor, Sukhwinder S. Shergill

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Review Psychology, Clinical

Are we failing clinical trials? A case for strong aggregate outcomes

D. W. Joyce, D. K. Tracy, S. S. Shergill

PSYCHOLOGICAL MEDICINE (2018)

Article Medicine, Research & Experimental

Cognitive Bias Modification for paranoia (CBM-pa): study protocol for a randomised controlled trial

Jenny Yiend, Antonella Trotta, Christopher Meek, Ilvana Dzafic, Nora Baldus, Bryony Crane, Thomas Kabir, Daniel Stahl, Margaret Heslin, Sukhwinder Shergill, Philip McGuire, Emmanuelle Peters

TRIALS (2017)

Article Health Care Sciences & Services

A Novel Virtual Reality Assessment of Functional Cognition: Validation Study

Lilla Alexandra Porffy, Mitul A. Mehta, Joel Patchitt, Celia Boussebaa, Jack Brett, Teresa D'Oliveira, Elias Mouchlianitis, Sukhi S. Shergill

Summary: In this study, a novel virtual reality shopping task called VStore was developed and its construct validity was established by comparing it with the established computerized cognitive battery, Cogstate. The results showed that VStore is sensitive to age-related cognitive decline and engages standard cognitive domains.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Article Psychiatry

White matter deficits in schizophrenia are global and don't progress with age

Richard A. Kanaan, Marco M. Picchioni, Colm McDonald, Sukhwinder S. Shergill, Philip K. McGuire

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)

Article Psychiatry

Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia

Jessica Foster, John Lally, Victoria Bell, Sukhi Shergill

BJPSYCH OPEN (2017)

Article Psychiatry

Rapid-onset clozapine-induced loss of glycaemic control: case report

Alejandro Porras-Segovia, Amir Krivoy, Mark Horowitz, George Thomas, Mark Bolstridge, Dragos Ion, Sukhwinder S. Shergill

BJPSYCH OPEN (2017)

Article Clinical Neurology

Stimulating thought: a functional MRI study of transcranial direct current stimulation in schizophrenia

Natasza D. Orlov, Owen O'Daly, Derek K. Tracy, Yusuf Daniju, John Hodsoll, Lorena Valdearenas, John Rothwell, Sukhi S. Shergill

BRAIN (2017)

Article Clinical Neurology

Stimulating cognition in schizophrenia: A controlled pilot study of the effects of prefrontal transcranial direct current stimulation upon memory and learning

Natasza D. Orlov, Derek K. Tracy, Daniel Joyce, Shinal Patel, Joanna Rodzinka-Pasko, Hayley Dolan, John Hodsoll, Tracy Collier, John Rothwell, Sukhwinder S. Shergill

BRAIN STIMULATION (2017)

Article Pharmacology & Pharmacy

Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit

Siobhan H. Gee, David M. Taylor, Sukhwinder S. Shergill, Robert Flanagan, James H. MacCabe

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)

No Data Available